Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Axcella Announces FDA IND Clearance Supporting Regulatory Path to Registration of AXA1125 for Long COVID Fatigue
Axcella Therapeutics, a clinical-stage biotechnology company pioneering novel approaches to treating complex diseases using multi-targeted […]
Investigational Therapy UGN-102 May Be Delivered at Home for the Treatment of Bladder Cancer
UroGen Pharma, a biotech company dedicated to developing and commercializing innovative treatment of urothelial and […]
Charles River and Purespring Therapeutics Announce Gene Therapy Manufacturing Collaboration
Charles River Laboratories International and Purespring Therapeutics, a pioneering gene therapy company focused on transforming […]
Bioved Pharmaceuticals announces the launch of its Proprietary Natural Products for Animal Health, with its Shwan Ayurved™ Science
Bioved Pharmaceuticals has announced the launch of its scientifically validated Natural Animal Health products from […]
Celanese Announces a Research Agreement with Johns Hopkins University to Advance Sustained Ocular Drug Delivery to the Suprachoroidal Space
Celanese Corporation, a global specialty materials and chemical company, today announced an agreement with Johns […]
Morphoceuticals Raises $8 million to Advance Electroceutical Approach to Regenerative Medicine
Morphoceuticals, a biotechnology company, announced it closed an $8 million Seed-2 funding round led by […]
Axogen Appoints Jens Schroeder Kemp as Chief Marketing Officer
Axogen, a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, […]
Josh Russell, AST, on Small Patch Applications for Drug Products
In this interview, Josh Russell from AST discusses the range of products offered by the […]
Mirum Pharmaceuticals Submits Supplemental New Drug Application for LIVMARLI in Patients with Cholestatic Pruritus in Progressive Familial Intrahepatic Cholestasis
Mirum Pharmaceuticals has announced that it has submitted a supplemental New Drug Application (sNDA) for […]
Ryne Biotechnology Awarded $4 Million from the California Institute for Regenerative Medicine
Ryne Biotechnology, a therapeutics company leveraging induced pluripotent stem cell (iPSC) technology to discover and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more